GlobeNewswire Inc.··DelveinsightFollicular Lymphoma Pipeline Heats Up: 45+ Companies Racing to Expand Treatment Options
Over 45 companies are developing 50+ follicular lymphoma therapies, with major pharma players advancing 5+ late-stage candidates using diverse mechanisms including protein degraders and kinase inhibitors.
BMYCELGrMRKAZNNRIXclinical trialsdrug development